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Abstract. Patient recruitment for clinical trials is expensive and has
been a significant challenge, with many trials not achieving their recruit-
ment goals. One method that shows promise for improving recruitment
is the use of interactive prompts that inform practitioners of patient el-
igibility for clinical trials during consultation. This paper presents the
ePCRN-IDEA recruitment system, which utilises an agent-based infras-
tructure to enable real-time recruitment of patients. In essence, whenever
patients enter a clinic, the system compares their details against eligi-
bility criteria, which define the requirements of active clinical trials. If
a patient is found to be eligible, a prompt is raised to notify the user.
In this way, it becomes possible for recruitment to take place quickly
in a cost effective manner, whilst maintaining patient trust through the
involvement of their own health care practitioner.
1 Introduction
Clinical trials are the gold standard by which medical research is evaluated.
They are used to study various aspects of medical science, as well as being a
vital stage in the deployment of new drug treatments. Currently, however, such
trials are frequently unsuccessful at recruiting sufficient patients. A review of the
UK Medical Research Council found that only 31% of trials actually recruited to
their planned target, with 30–40% of costs arising during the recruitment phase
alone [1]. This is because discovering and contacting eligible potential recruits is
both logistically and legally challenging. Consequently, many research projects
take far longer to complete than is desirable, resulting in an unnecessary burden
for those who could potentially benefit from the results.
The main challenge for patient recruitment lies in locating and contacting
patients in a sufficiently timely manner to allow them to participate. However,
the ease with which this can be done varies dramatically with the type of trial;
for instance, recruitment can be challenging for trials that have high recruit-
ment targets or complex eligibility criteria. Currently, recruitment is performed
in a highly laborious manner, which is ill-suited to the above situations. It often
involves a human recruitment agent visiting clinics in an attempt to locate suit-
able patients (e.g. asking practitioners or searching local medical records). This
creates significant overhead as it is both slow and costly, as well as non-scalable
2for most trials. For example, a trial investigating rare ailments might need an
extensive number of visits to locate sufficient patients.
In consequence, it is of paramount importance to address the recruitment
challenges within trials to ensure the future efficacy of medical research. It is
therefore necessary to find a scalable way by which eligible patients can be
discovered. To address this, we propose replacing human agents with software
agents that permanently reside within clinics, with the aim of searching for
patients who might satisfy trial eligibility criteria. Through this, the agent could
inspect patient information in real-time to ascertain eligibility before presenting
notifications to local practitioners. Importantly, by using a software agent this
could be done rapidly within a consultation before a patient has left, thereby
shortening the recruitment lifecycle (as well as enabling trials based on incidental
cases). The paper’s contributions are therefore as follows:
– A critique of existing clinical trial recruitment approaches, highlighting that
current techniques are both slow and expensive.
– An agent-based distributed architecture called ePCRN-IDEA that enables
real-time recruitment of patients, whilst avoiding the key limitations of ex-
isting approaches.
– A procedure by which software agents can guide the recruitment of patients
to their most appropriate trials.
The rest of the paper is structured as follows; first the background to the
research is discussed in Section 2 before detailing the ePCRN-IDEA recruit-
ment system in Section 3. Following this, a discussion is presented in Section 4,
alongside future work and conclusions.
2 Background and Related Work
2.1 Recruitment in Clinical Trials
Clinical trials are a challenging stage in the research of clinicians due to the
complexity of recruiting patients for participation. Many types of trials can suf-
fer from such difficulties; for instance, trials that have potential recruits who are
widely distributed over many clinics (e.g. primary care) are extremely difficult to
recruit for due to the intense resource requirements. Similarly, trials with certain
types of patient eligibility criteria can be difficult to recruit for; for example, a
trial dealing with incidental/acute conditions would need a practitioner to imme-
diately identify patients in real-time. This can be highly challenging, especially
when dealing with complex eligibility criteria or trials that require immediate
actions (e.g. a change of drug treatments). This has a significant impact on med-
ical research and stunts potential life-saving advances. Recruitment is currently
performed in a number of ways; examples include:
– Recruitment Visits: Using recruiters to visit or contact practices so that they
can search local medical records and/or ask local practitioners.
3– Advertisements: Using posters, web sites, mailing lists or newspaper adverts
describing what is required for the trial.
– Practitioners: Using practitioners to suggest patients who might be eligible.
Alternatively, practitioners may be asked to look for patients (during consul-
tations) who match the criteria in real-time.
Clearly, the above approaches are slow and often quite expensive. The pre-
dominant approach of employing recruiters to contact and visit clinics is labori-
ous and often infeasible, especially when dealing with the above types of trials.
For instance, different clinics often use different database systems, thereby re-
quiring a high degree of training for recruiters; something that is exacerbated by
the limited in-house IT training in many clinics. Further, attempts to standard-
ise this database search procedure (e.g. MIQUEST) are often poorly understood
by researchers, whilst such standards can often be undermined by variations in
coding and medical dictionaries (e.g. if multiple databases use different seman-
tics). Consequently, there is little automated support for finding eligible patients,
often leaving recruitment very much as an ad-hoc process that falls outside of
recognised standards; Moreover, there is little infrastructure available that can
be exploited by clinicians to assist in the stage.
As an alternative to the recognised approaches, Embi et. al. [2] propose the
use of a Clinical Trial Alert (CTA) system, through which practitioners could be
notified while they are in consultation with a patient who is eligible for a trial.
Their work shows that significant increases in recruitment could be achieved.
However, their pilot study was only deployed in a single clinic with a single trial,
in an attempt to study the improvements in recruitment. Other similar tech-
niques have also seen only limited large-scale testing, e.g. [3]. Consequently, a
number of issues (e.g. scalability) have not been investigated, leaving the sole
focus on the recruitment outcomes. To address these concerns, this paper there-
fore focusses on more infrastructural aspects for enabling a large-scale trial alert
system, specifically through the use of intelligent agents.
2.2 Agents in Healthcare
Agents have emerged as a prominent technology for handling a range of real-
world problems [4]. An agent can be defined as “a computer system that is
situated in some environment, and that is capable of autonomous action in their
environment in order to meet its delegated objectives” [5]. Agents in healthcare
have seen widespread investigation; in general, their use attempts to address en-
demic issues such as (i) distributed information and expertise, (ii) unpredictable
dynamics, and (iii) uncertainty in reasoning and data.
For example, MAID [6] is an agent-based system for integrating heteroge-
neous data sources within a hospital environment. The hospital studied had
24 departments, each using their own information systems. To address this,
agents were constructed to interoperate with each system to monitor changes
and retrieve data for insertion into a central repository. In a subsequent work,
HealthAgents [7] went beyond MAID to also enable decision support, specifically
4for diagnosing brain tumours. A range of agent-based systems have also been pro-
posed for handling distributed expertise. These includes using agents to enable
better communication between healthcare workers based on ambient informa-
tion, e.g. their role, location etc. [8], as well as using agents to remotely monitor
patients [9][10]. These systems also often involved data analysis; S(MA)2D [10],
for instance, uses statistical analysis to cluster patients into similar groups. This
ability to scalably perform data analysis in real-time, clearly, also shows poten-
tial for enabling the type of eligible patient identification discussed previously.
Despite this, so far little work has been performed into using agents to improve
clinical trial recruitment. Consequently, the rest of this paper explores exploiting
the properties of agents to enable real-time recruitment of patients to trials.
3 ePCRN-IDEA Recruitment System
This section presents the ePCRN-IDEA recruitment system, which is designed
to enable real-time identification of eligible patients. We first present the over-
all architecture before describing the individual components, focussing on the
behaviour of the clinic-based agents.
3.1 Overview
The core goal of the ePCRN-IDEA recruitment system is to improve patient
recruitment. In order to do so, researchers must formally define the eligibility
criteria of participants, then distribute it to software agents that reside locally
on practitioners’ computers. These software agents listen to interactions between
the practitioner’s local Electronic Healthcare Record (EHR) database and the
user in an attempt to locate patients who are eligible for trials. Importantly,
this occurs in real-time during the consultation, thereby allowing a pop-up to be
generated, notifying the practitioner of the patient’s eligibility. In this way, the
patient can be instantly consulted regarding the trial and, if interested, recruited
via a web interface. The key architectural entities in the system are as follows:
– LEPIS: An agent that resides at primary care practices and investigates the
eligibility of any present patients, termed the Local Eligible Patient Identifi-
cation Service.
– CCS: A point of storage and distribution that allows clinical researchers to
inject new trials into the system, termed the Central Control Service.
– CTMS: A website that handles the actual recruitment process once an eligible
patients has been discovered, termed the Clinical Trial Management System.
Prototype implementations of all these components have already been de-
veloped. Fig. 1 provides an overview of these, as detailed in the rest of this
section.
5Fig. 1. Overview of ePCRN System
3.2 Central Control Service (CCS)
A trial store maintains a repository of active trials within the system, as entered
by any clinical researchers wishing to recruit patients. Trials are stored using
a standard model (the PCROM standard [11]), which defines the data format
used to represent the various aspects of the trials. This includes a description
of the trial as well as the eligibility criteria, which can be based on a variety of
aspects ranging from a pre-computed list of eligible patient identifiers to complex
diagnosis information. The trial store is realised within the ePCRN-IDEA system
through the Central Control Service (CCS), which is a service used to manage
all the trials. When a new trial is created, it is injected into the system via the
CCS and stored in a MySQL database back-end before being made accessible
to the appropriate (and authorised) parties — namely, the recruitment agents.
These are accessed securely using an encrypted SQL connection initiated by each
agent to the CCS.
3.3 Local Eligible Patient Identification Service (LEPIS)
The Local Eligible Patient Identification Service (LEPIS) is a Java-built soft-
ware agent that resides on every practitioner’s PC (who is authorised to recruit
patients). The purpose of this agent is to actively discover any eligible patients
who might be seen by the practitioner. It therefore operates as a replacement for
the existing human agents who visit clinics in an attempt to locate suitable pa-
tients. Every LEPIS agent is required to obtain two distinct sets of information.
First, it must acquire information about patients in real-time as they enter the
clinic. Second, LEPIS must also acquire the necessary trial information (from
the CCS) so that it can compare patients against each trial’s eligibility criteria;
ideally, eligibility should also be computed locally to avoid unnecessary delays
or bottlenecks.
Accessing Patient Information To discover the eligibility of a patient for a
trial, it is first necessary for LEPIS to gain access to any pertinent information
6related to the patient. Whenever a patient enters a clinic, the practitioner opens
his or her medical record using the Electronic Healthcare Record (EHR) database
on their desktop computer. This medical record contains a range of demographic
and medical information about the patient, allowing practitioners to retrieve
information about the patient during the consultation, as well as enter new
information. This offers an existing platform through which a recruitment agent
can access information about patients. We have modified a popular EHR system,
Vision [12], to interact with LEPIS. Whenever a patient record is opened or
modified, the information is passed to LEPIS (through a standard file using a
shared XML schema) so that it can attempt to locate trials for which the patient
may be eligible. Information is coded using standard Read Codes and Multilex
Drug Codes to allow LEPIS and the EHR to understand each other. LEPIS
is therefore given real-time access to information about any patients who are
currently in consultation. Although, evidently, eligibility criteria is limited to
those attributes provided by the EHR, which can vary based on both policy and
EHR implementation (many EHR vendors exist).
Accessing Trial Information To allow a LEPIS agent to compute a patient’s
eligibility, it must first gain access to trial information. Ideally, this should be
stored locally to enable real-time eligibility checks within a consultation. How-
ever, evidently, this is largely infeasible with the huge number of active trials run-
ning; e.g. clinicaltrials.gov currently lists well over 100,000 trials. Consequently,
it is necessary for each agent to independently select the most appropriate trials
for its clinic and practitioner. Each agent thus maintains a set of trials T of size
n, as limited by the host’s local resources. An agent therefore selects n based
on the capabilities of its host, by performing eligibility checks on a random set
of trials repeatedly for one second; n is then set as the number of iterations. It
then keeps a persistent record of all patient identifiers, Read Codes and Multi-
lex Codes provided by the EHR to build up a profile of the clinic. Using this
information, n trials are retrieved from the CCS through the following process:
1. LEPIS attempts to retrieve a set of n trials from the CCS containing:
a) p trials that includes a known patient registered within the clinic (p =<
n);
b) if p < n, c trials that includes coded information previously encountered
within the clinic (c =< n− p); and
c) if p+ c < n, r randomly selected trials (r =< n− p− c).
2. Remove any trials that are fully recruited.
These two steps are repeated throughout an agent’s lifetime with a config-
urable interval, which is set to 24 hours by default.
Computing Eligibility and Generating a Popup When LEPIS acquires
patient information from the EHR, it must compare it against the eligibility
criteria of any known trials. This is a simple process that currently involves
iteratively computing eligibility for each known trial and then selecting a random
one if multiple are found. A popup is then generated to notify the user. Fig. 2
shows a screenshot of the user interface.
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3.4 Clinical Trial Management System (CTMS)
If a patient is interested in being recruited for a particular trial, it is then neces-
sary to actually perform the recruitment procedure. This is not handled by the
local agent; instead, an external website is used, called the Clinical Trial Man-
agement System (CTMS). The CTMS is securely accessed by the practitioner
and then used to register the patient’s interest in being recruited. Any necessary
steps can then be taken, e.g. contacting the patient, recording information etc.
4 Discussion, Future Work and Conclusion
The ePCRN-IDEA recruitment systems differs substantially from previous work
in that it is agent-based. Our early evaluation shows that the agent-based ap-
proach is promising and has several potential advantages over traditional client-
server approaches (e.g [2]). Through the use of agents, intelligence is decen-
tralised within the system so that both computation and decision making is
independently performed by each agent.
Primarily, we have used the approach to enable superior scalability. This is
critical, especially for patient recruitment in primary care. Even for common dis-
eases, eligible patients are thinly spread across many practices, which potentially
number several thousand. In the UK, alone, there are more than 10,000 practices.
A client-server approach could be realised in two ways: either all patient infor-
mation could be transmitted to a server, where it centrally computes eligibility;
or all trial information could be transmitted to all clinics for local computation.
The former is non-scalable as well as dangerous in terms of privacy and secu-
rity. The latter, however, is also highly non-scalable as the number of trials (e.g.
greater than 100,000) alongside the size of each trial description (e.g. 0.5 MB)
makes it impossible for all clinics to know of all trials. Consequently, to address
this, we embed intelligence within the agents to learn how to best select trials
8for their host clinic, exploiting the local knowledge (and computational abilities)
of each agent, rather than burdening a central point.
From our initial phase-1 prototype we have identified a number of future
lines of work. First, we aim to complete a full system deployment within the UK
primary healthcare system, thereby enabling a detailed quantitative evaluation.
Beyond this, we also intend to extend the agent capabilities. Key research lines
include, (i) inter-agent collaboration: allowing agents to build societies to better
enable information and resource sharing (e.g. based on disease areas, localities);
(ii) interface adaptation: allowing agents to learn (and share) the behaviour of
users to adapt interaction; and (iii) trial negotiation: allowing agents to negotiate
with each other to best distribute trials based on runtime conditions.
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